Patient positioning and braces for pain relief and spinal stability in metastatic cord compression in adults (Protocol)
Cox
T A B L E O F C O N T E N T S
. As a result, one guideline suggests that patients with a short life expectancy should be in a sitting-up position to avoid the aforementioned complications related to bed rest (Jacobs 1999). An additional complicating factor to positioning is the increased pain experienced by patients with spinal instability whilst sitting or standing due to an increased axial load on the spine (Bilsky 1999). Despite these recommendations, no clear guidelines have been established about how to correctly position patients in order to maintain spinal stability and relieve pain. To ensure patients are cared for effectively and to ensure health care professionals are advised appropriately how to provide this care it is imperative that a review of patient postioning, bracing and spinal stability is undertaken.
O B J E C T I V E S
To investigate the correct positions for patients with MSCC and examine the effects of spinal bracing to relieve pain or vertebral collapse under physiological load, or both, in patients with MSCC.
M E T H O D S Criteria for considering studies for this review

Types of studies
Studies to be included are randomised controlled trials (RCTs).
Types of participants
Participants to be included will be adults of either gender. Participants must be diagnosed with MSCC. Any participants with a previous stabilising procedure such as internal brace surgery will be excluded.
Types of interventions
Interventions will include participants who receive bracing therapy or guidance for positioning, or both, e.g. lying flat, sitting up, standing or mobilised, or both, versus patients who receive no therapy or no positioning guidance, or neither. Where data exists comparisons of interventions on outcome measures will be made.
Types of outcome measures
• The primary outcomes will be the effect of bracing on vertebral collapse under physiological load, pain relief quality of life and patient satisfaction. Vertebral collapse will be measured by vertebral column collapse rate, number of vertebrae involved in the problem area and bony impingement. Validated scales to measure pain relief should be used in the studies (e.g. visual analogue scales (VAS), categorical scales and pain intensity scales), quality of life (e.g. EORTC) and patient satisfaction should also be used and it should be taken into account that patients will already be on analgesics.
• Adverse events will include increased pain and increased spinal instability.
Search methods for identification of studies Electronic searches
The search strategy detailed in Appendix 1 will be applied to the following databases: • CENTRAL (in The Cochrane Library) current issue.
The search strategy detailed in Appendix 1 will be applied to the CENTRAL database and the search strategy in Appendix 2 will be applied to the MEDLINE and OVID databases.
Searching other resources
Additional references will be located through searching the bibliographies of identified studies. The physician data query will be checked for any current clinical trials related to the research questions.
Data collection and analysis
Assessment of methodological quality
Two review authors will independently assess each eligible study for inclusion in the review and for its quality. Disagreements over inclusion will be resolved by discussion or with a third review author, or both. Assessment of methodological quality will be assessed and graded, using the 'Risk of bias' table available within RevMan 5 each study will be graded eligible, ineligible or unclear. If necessary additional information will be sought from the principal investigator of a study for clarification of published data or missing data.
Data extraction
Two tables will be produced, one outlining 'Characteristics of included studies' and the other detailing the 'Characteristics of excluded studies'. Details for the reason of exclusion will be given. We will extract key information on a standardised data extraction form. This will include where available:
• general information e.g. author, title, contact address, year of study, country of study, language of publication, year of publication;
• study characteristics e.g. design (randomised or non randomised), randomisation method, manner of recruitment, sampling, duration of intervention period, length of follow-up, reason and number of drop-outs, adverse events;
• participants e.g. source of primary tumours, level of involvement, inclusion;
• intervention e.g. detailed description of controlled intervention, mode, intensity, duration;
• outcomes e.g. specific outcome reported, assessment instrument used, scoring range;
• economic data e.g. cost;
• service provision e.g. resource allocation.
It is envisaged that the main outcome measures will be in the form of continuous data, reporting a comparison between treatment and control group levels of pain, functional disability or quality of life scores, or both. It is likely that validated scales will be used to assess the size of this effect e.g. If homogeneity across the studies can be established we will pool the studies for meta-analysis using the fixed-effect model. If I 2 is greater than 50% (heterogeneity) random-effects will be used. If it is not possible to pool data we will provide a narrative account.
